Clinical Trials Directory

Trials / Sponsors / Equillium

Equillium

Industry · 7 registered clinical trials.

StatusTrialPhaseStarted
CompletedStudy of EQ101 in Adult Subjects With Moderate to Severe Alopecia Areata
Alopecia Areata, Alopecia, Alopecia Totalis
Phase 22022-12-19
TerminatedA Study of Itolizumab in Combination With Corticosteroids for the First-Line Treatment of Acute Graft Versus H
Graft Versus Host Disease, GVHD, Acute-graft-versus-host Disease
Phase 32022-04-29
WithdrawnPhase 2 Trial of BNZ-1 in Patients With Moderate to Severe Alopecia Areata
Alopecia Areata, Alopecia Totalis, Alopecia Universalis
Phase 22021-10-01
WithdrawnA Study to Evaluate the Efficacy and Safety of Itolizumab in Subjects Hospitalized With COVID-19
Coronavirus
Phase 32020-11-01
CompletedStudy of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis
Lupus Erythematosus, Lupus Nephritis
Phase 12019-10-01
CompletedA Study to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity of EQ001 in Subjects With aGVHD
Acute-graft-versus-host Disease, aGVHD, GVHD
Phase 1 / Phase 22019-07-15
CompletedA Study of Itolizumab (EQ001) to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity in Uncontrol
Asthma
Phase 12019-06-20